Advances in laser scanning imaging cytometry for high-content screening.

Area of Science:

• Biotechnology
• Drug Discovery
• Cellular Imaging

Background:

• High-content screening (HCS) revolutionized drug discovery workflows over a decade ago.
• Cell-based assays are crucial for target identification, screening, lead optimization, and toxicity assessment.
• Laser scanning imaging cytometry (LSIC) is a key HCS technology enabling detailed cellular analysis.

Purpose of the Study:

• To review advancements in LSIC technology.
• To showcase the application of LSIC in various drug discovery assays.
• To highlight real-world case studies demonstrating LSIC's utility.

Main Methods:

• LSIC utilizes laser scanning excitation with an F-theta scan lens for rapid, high-resolution whole-well imaging.
• Modern LSIC systems incorporate multiple lasers and detectors for spectral analysis, enabling multiplexing.
• The technology is applied to a wide range of fluorescently labeled cell-based assays.

Main Results:

• LSIC allows for the identification and quantification of compound effects on multiple cellular functions.
• Increased multiplexing capabilities enhance the depth of cellular analysis.
• LSIC is extensively used for phenotypic screening, including cell health and RNA interference (RNAi) studies.

Conclusions:

• LSIC is a powerful tool for characterizing chemical libraries and accelerating drug discovery.
• Its application in phenotypic screening, particularly with 3D cell models, is expanding.
• Advancements in LSIC technology continue to improve throughput and analytical capabilities for drug development.